Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
marketing materials and screenshot from Applicant's websites http://www.yescartahospitalbillingcoding.com and
http://www.yescarta.com/lbcl/what-is-car-t-cell-therapy downloaded on February 6, 2023 displaying the mark in use
Providing medical information; providing a web site featuring medical information; providing medical information, consultancy and advisory
services; collection and preservation of biological tissue, blood and cells
screenshot form Applicant's website www.tecartushcp.com/car-t-cell-therapy/mantle-cell-lymphoma/adverse-events downloaded on February
6, 2023 displaying the mark in use
screenshot from Applicant's website www.kitekonnect.com downloaded on February 6, 2023 displaying the mark in use
WEBPAGE URL
www.kitekonnect.com
WEBPAGE DATE OF ACCESS
02/06/2023
ATTORNEY INFORMATION
NAME
Cynthia Smuzynska
ATTORNEY DOCKET NUMBER
TBD
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Gilead Sciences, Inc.
STREET
333 Lakeside Drive
CITY
Foster City
STATE
California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
94404
PHONE
650-522-5563
FAX
650-522-5575
EMAIL ADDRESS
trademarks@gilead.com
OTHER APPOINTED ATTORNEY
Gretchen R. Stroud; Jack Wessel; Lori Mayall; Shelley Lai; Peter Colosi
CORRESPONDENCE INFORMATION
NAME
Cynthia Smuzynska
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
trademarks@gilead.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
TMTeam@gilead.com
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
4
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
1400
*TOTAL FEES PAID
1400
SIGNATURE INFORMATION
SIGNATURE
/cynthia smuzynska/
SIGNATORY'S NAME
Cynthia Smuzynska
SIGNATORY'S POSITION
Senior Counsel, IP
SIGNATORY'S PHONE NUMBER
650-522-5563
DATE SIGNED
02/07/2023
SIGNATURE METHOD
Sent to third party for signature
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97784457
Filing Date:02/07/2023
To the Commissioner for Trademarks:
MARK: KITE (Standard Characters, see mark)
The literal element of the mark consists of KITE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Kite Pharma, Inc., a corporation of Delaware, having an address of
2400 Broadway
Santa Monica, California 90404
United States
650-522-5575(fax)
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 036: Financial administration of patient reimbursement programs; financial administration of medication reimbursement programs and services
In International Class 036, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 01/01/2020, and first used in
commerce at least as early as 01/01/2020, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) Screenshot from Applicant's website www.kitekonnect.com downloaded on February 6, 2023 displaying the mark in use.
International Class 040: Custom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy
In International Class 040, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 06/30/2020, and first used in
commerce at least as early as 06/30/2020, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) marketing materials and screenshot from Applicant's websites http://www.yescartahospitalbillingcoding.com and
http://www.yescarta.com/lbcl/what-is-car-t-cell-therapy downloaded on February 6, 2023 displaying the mark in use.
International Class 044: Providing medical information; providing a web site featuring medical information; providing medical information, consultancy and advisory services; collection and
preservation of biological tissue, blood and cells
In International Class 044, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 06/25/2021, and first used in
commerce at least as early as 06/25/2021, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) screenshot form Applicant's website www.tecartushcp.com/car-t-cell-therapy/mantle-cell-lymphoma/adverse-events downloaded on February 6,
2023 displaying the mark in use.
International Class 045: Providing patient advocate services in the field of the treatment of diseases and disorders
In International Class 045, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 01/01/2020, and first used in
commerce at least as early as 01/01/2020, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) screenshot from Applicant's website www.kitekonnect.com downloaded on February 6, 2023 displaying the mark in use.
For informational purposes only, applicant's website address is: www.kitepharma.com
The owner's/holder's proposed attorney information: Cynthia Smuzynska. Other appointed attorneys are Gretchen R. Stroud; Jack Wessel; Lori Mayall; Shelley Lai; Peter Colosi. Cynthia Smuzynska of
Gilead Sciences, Inc., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
333 Lakeside Drive
Foster City, California 94404
United States
650-522-5563(phone)
650-522-5575(fax)
trademarks@gilead.com
The docket/reference number is TBD.
Cynthia Smuzynska submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1400 has been submitted with the application, representing payment for 4 class(es).
Declaration
Declaration Signature
Signature: /cynthia smuzynska/ Date: 02/07/2023
Signatory's Name: Cynthia Smuzynska
Signatory's Position: Senior Counsel, IP
Signatory's Phone Number: 650-522-5563
Signature method: Sent to third party for signature
Payment Sale Number: 97784457
Payment Accounting Date: 02/07/2023
Serial Number: 97784457
Internet Transmission Date: Tue Feb 07 16:05:53 ET 2023
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-202302071605536
36812-97784457-86027e81d87d847b834d68c83
ac1a93f88fc73d7969cd8856dbdfa32461e3ff48
-DA-05532768-20230206191148605180